SCHRODER INVESTMENT MANAGEMENT GROUP - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$843,000
+46.9%
37,701
+57.2%
0.00%
+100.0%
Q4 2018$574,000
-52.3%
23,989
-45.6%
0.00%
-50.0%
Q3 2018$1,204,000
-0.2%
44,1360.0%0.00%0.0%
Q2 2018$1,207,000
+29.1%
44,136
+50.2%
0.00%0.0%
Q1 2018$935,000
+49.8%
29,376
+77.9%
0.00%
+100.0%
Q4 2017$624,000
-35.1%
16,511
-57.7%
0.00%
-50.0%
Q3 2017$961,00039,0670.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders